Document Classification

Section Type: RESULTS

Text: Change in UACR was : 3 % (from 61 to 60 mg/mmol ; 95 % CI 16 to 13) in the placebo group ; 16 % (from 62 to 51 mg/mmol ; 24 to 9) in the combined paricalcitol groups, with a between-group difference versus placebo of 15 % (95 % CI 28 to 1 ; p = 0. 071) ; 14 % (from 63 to 54 mg/mmol ; 24 to 1) in the 1 g paricalcitol group, with a between-group difference versus placebo of 11 % (95 % CI 27 to 8 ; p = 0. 23) ; and 20 % (from 61 to 49 mg/mmol ; 30 to 8) in the 2 g paricalcitol group, with a between-group difference versus placebo of 18 % (95 % CI 32 to 0 ; p = 0. 053).